A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer

Clinical trial NCT06953999 · RECRUITING

Trial details

NCT number: NCT06953999
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2025-06-11
Primary completion: 2027-05-14
Enrollment: 999

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.